This case study describes how a global evidence-generation company modernized a highly configurable clinical trials and supply management platform by migrating from a legacy monolith to a multi-tenant SaaS model with Single Sign-On to improve predictability, standardization, and cost-effectiveness. Key drivers included rising infrastructure costs, inefficient customer onboarding, low automation that extended test cycles, and the need to revamp architecture without disrupting critical operations for forecasting, labeling, distribution, reconciliation, and real-time visibility. Brillio delivered a holistic SaaS solution spanning onboarding through offboarding, decomposed capabilities into domain-driven microservices with modular deployment, added role-based SSO, and implemented an automation

Join for free to read